NXS 10.7% 33.5¢ next science limited

Bacterial biofilms are most problematic where topical treatments...

  1. 6,997 Posts.
    lightbulb Created with Sketch. 1791
    Bacterial biofilms are most problematic where topical treatments (detoll, iodine etc) would be ineffective if applied; BlastX’s primary market is for use during surgery.

    It sounds like a product with a lot of promise. Changing surgical behaviours to adopt this product is where the hard work currently is; over time the efficacy of the product should speak for itself.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.040(10.7%)
Mkt cap ! $97.71M
Open High Low Value Volume
36.0¢ 36.0¢ 33.0¢ $9.503K 27.37K

Buyers (Bids)

No. Vol. Price($)
1 1499 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 302 2
View Market Depth
Last trade - 16.10pm 16/05/2024 (20 minute delay) ?
Last
33.5¢
  Change
-0.040 ( 10.7 %)
Open High Low Volume
36.3¢ 37.0¢ 33.5¢ 25927
Last updated 15.58pm 16/05/2024 ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.